Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,658
Closed -$292K 990
2025
Q1
$292K Sell
1,658
-145
-8% -$28.1K 0.04% 325
2024
Q4
$354K Buy
1,803
+64
+4% +$13.5K 0.05% 301
2024
Q3
$353K Buy
1,739
+201
+13% +$47.4K 0.05% 301
2024
Q2
$325K Buy
1,538
+49
+3% +$11.1K 0.05% 286
2024
Q1
$341K Sell
1,489
-2,229
-60% -$520K 0.05% 281
2023
Q4
$860K Sell
3,718
-164
-4% -$33.7K 0.12% 192
2023
Q3
$764K Buy
3,882
+1
+0% +$217 0.12% 200
2023
Q2
$872K Buy
3,881
+40
+1% +$8.03K 0.14% 180
2023
Q1
$764K Buy
3,841
+5
+0.1% +$1.07K 0.13% 190
2022
Q4
$786K Buy
3,836
+150
+4% +$30.4K 0.14% 176
2022
Q3
$668K Buy
3,686
+1
+0% +$219 0.12% 191
2022
Q2
$800K Buy
3,685
+1,512
+70% +$328K 0.15% 173
2022
Q1
$474K Buy
+2,173
New +$515K 0.09% 248

Other funds holding IQV

Continuum Advisory's IQV Position: Q2 2025 in Review

Continuum Advisory sold out of IQVIA (IQV) in Q2 2025, closing a stake of 1,658 shares — an estimated $292K sold.

Continuum Advisory first reported a position in IQV in Q1 2022 and held it in 13 quarters. The position peaked at $872K in Q2 2023. 978 funds tracked by Wall St. Rank hold IQV as of Q2 2025.

  • Continuum Advisory reported no remaining IQVIA position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 1,658 IQVIA shares in Q2 2025, an estimated $292K.
  • Continuum Advisory first reported a position in IQVIA in Q1 2022 and held it in 13 quarters.
  • Continuum Advisory's IQVIA position peaked at $872K in Q2 2023.
  • 978 funds tracked by Wall St. Rank held IQVIA as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.